A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers

NCT07539415 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity & Overweight
Type 2 Diabetes

Interventions

DRUG: DWRX5003
DRUG: DWC202502
DRUG: DWC202503
OTHER: DWRX5003P

Sponsor

Daewoong Pharmaceutical Co. LTD.